metastasis

Open Access
Neutrophils in cancer: from immune defense to tumor promotion
Zhen Wang, Hanwen Hu, Yunjia Bao, Liwei Pang and Chenghui Yang

Cancer Biology & Medicine July 2025, 20250023; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0023
Open Access
Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer
Xiuzhi Zhu, Xiaohan Ying, Yin Liu, Yunyi Wang, Li Chen, Zhiming Shao, Xi Jin, Yizhou Jiang and Zhonghua Wang

Cancer Biology & Medicine September 2024, 21 (9) 784-798; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0009
Open Access
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis
Shirong Tan, Xiangyu Sun, Haoran Dong, Mozhi Wang, Litong Yao, Mengshen Wang, Ling Xu and Yingying Xu

Cancer Biology & Medicine July 2024, 21 (7) 606-635; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0309
You have access
Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers
Juan Hui, Mingzhen Zhou, Guangzhou An, Hui Zhang, Yuanyuan Lu, Xin Wang and Xiaodi Zhao

Cancer Biology & Medicine August 2023, 20 (8) 575-598; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0119
You have access
Therapeutic implications of cancer stem cells in prostate cancer
Pinaki Banerjee, Prachi Kapse, Shehnaz Siddique, Moumita Kundu, Jasoda Choudhari, Varshasnata Mohanty, Diksha Malhotra, Suresh W. Gosavi, Rajesh N. Gacche and Gopal C. Kundu

Cancer Biology & Medicine June 2023, 20 (6) 401-420; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0714
You have access
Combined chemo-endocrine therapy as a potential new option for HR+/HER2− advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine
Xue Wang, Jian Yue, Yikun Kang, Zhong Dai, Jie Ju, Jiayu Wang, Pin Zhang, Fei Ma, Binghe Xu and Peng Yuan

Cancer Biology & Medicine April 2023, 20 (4) 287-296; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0702
You have access
Akt isoforms differentially provide for chemoresistance in prostate cancer
Bo Ma, Hanshuang Shao, Xia Jiang, Zhou Wang, Chuanyue (Cary) Wu, Diana Whaley and Alan Wells

Cancer Biology & Medicine May 2022, 19 (5) 635-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0747
You have access
CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
Rosaria A. Fontanella, Silvia Sideri, Chiara Di Stefano, Angiolina Catizone, Silvia Di Agostino, Daniela F. Angelini, Gisella Guerrera, Luca Battistini, Giulia Battafarano, Andrea Del Fattore, Antonio Francesco Campese, Fabrizio Padula, Paola De Cesaris, Antonio Filippini and Anna Riccioli

Cancer Biology & Medicine August 2021, 18 (3) 788-807; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0495
You have access
Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma
Meina Jiang, Shuai Fang, Xiaodong Zhao, Chengwei Zhou and Zhaohui Gong

Cancer Biology & Medicine May 2021, 18 (2) 411-420; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0238
You have access
Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression
Xiaofan Wei and Hongquan Zhang

Cancer Biology & Medicine May 2020, 17 (2) 270-281; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0420

Main menu

User menu

Search

metastasis

Pages

Navigate

More Information

For Authors

Journal Services